227 related articles for article (PubMed ID: 9577513)
1. Long acting beta 2 agonists and the risk of life threatening asthma.
Ernst P
Thorax; 1998 Jan; 53(1):1-2. PubMed ID: 9577513
[No Abstract] [Full Text] [Related]
2. Asthma mortality and beta-agonists.
Skorodin MS
Chest; 1995 Dec; 108(6):1768. PubMed ID: 7497807
[No Abstract] [Full Text] [Related]
3. Case-control study of salmeterol and near-fatal attacks of asthma.
Williams C; Crossland L; Finnerty J; Crane J; Holgate S; Pearce N; Beasley R
Thorax; 1998 Jan; 53(1):7-13. PubMed ID: 9577515
[TBL] [Abstract][Full Text] [Related]
4. Evidence based answers--is salmeterol safe in asthma?
Spurling G; Doust J
Aust Fam Physician; 2006 Aug; 35(8):625-6. PubMed ID: 16894440
[No Abstract] [Full Text] [Related]
5. Beta 2 agonists and asthma.
Rees J
BMJ; 1991 May; 302(6786):1166-7. PubMed ID: 1675134
[No Abstract] [Full Text] [Related]
6. Salmeterol: a long-acting beta 2-agonist for asthma.
Nurse Pract; 1994 Jul; 19(7):9-10. PubMed ID: 7936460
[No Abstract] [Full Text] [Related]
7. Safety of long-acting beta-agonists--an urgent need to clear the air.
Martinez FD
N Engl J Med; 2005 Dec; 353(25):2637-9. PubMed ID: 16371628
[No Abstract] [Full Text] [Related]
8. Beta2 déjà vu.
O'Byrne PM; Adelroth E
Chest; 2006 Jan; 129(1):3-5. PubMed ID: 16424402
[No Abstract] [Full Text] [Related]
9. Exacerbations of asthma in patients on salmeterol.
Jenkins MM; Hilton CJ; de Kock JC; Palmer JB
Lancet; 1991 Apr; 337(8746):913-4. PubMed ID: 1672988
[No Abstract] [Full Text] [Related]
10. Comments on the Salmeterol Multicenter Asthma Research Trial.
Seymour SM; Sullivan EJ; Chowdhury BA; Meyer RJ; Davi RC
Chest; 2006 Sep; 130(3):930-1; author reply 931. PubMed ID: 16963702
[No Abstract] [Full Text] [Related]
11. Salmeterol (Serevent) asthma trial halted early.
Wooltorton E
CMAJ; 2003 Mar; 168(6):738. PubMed ID: 12642431
[No Abstract] [Full Text] [Related]
12. Why SMART about second-line treatment when first-line treatment is being ignored?
Currie GP
Chest; 2006 Sep; 130(3):929; author reply 929. PubMed ID: 16963701
[No Abstract] [Full Text] [Related]
13. Long-acting beta-agonists, tachyphylaxis, and corticosteroids.
Sears MR
Chest; 1996 Apr; 109(4):862-4. PubMed ID: 8635359
[No Abstract] [Full Text] [Related]
14. Are there any detrimental effects of the use of inhaled long-acting beta 2-agonists in the treatment of asthma?
Devoy MA; Fuller RW; Palmer JB
Chest; 1995 Apr; 107(4):1116-24. PubMed ID: 7705125
[No Abstract] [Full Text] [Related]
15. Cause of death in the SMART Trial.
Williams C
Chest; 2006 Sep; 130(3):929-30; author reply 930. PubMed ID: 16963700
[No Abstract] [Full Text] [Related]
16. Safety of long-acting beta-agonists: urgent need to clear the air remains.
Beasley R; Martinez FD; Hackshaw A; Rabe KF; Sterk PJ; Djukanovic R
Eur Respir J; 2009 Jan; 33(1):3-5. PubMed ID: 19118222
[No Abstract] [Full Text] [Related]
17. Pharmacogenetics of beta(2)-agonists in children.
Kabesch M
J Allergy Clin Immunol; 2009 Dec; 124(6):1195-6. PubMed ID: 19910024
[No Abstract] [Full Text] [Related]
18. Salmeterol xinafoate in asthma.
Palmer JB; Oxford JM
JAMA; 1994 Nov 23-30; 272(20):1575-6. PubMed ID: 7966861
[No Abstract] [Full Text] [Related]
19. [More asthma death cases with beta-2-antagonists: with inhaled corticosteroids on the safe side?].
Wepner U
MMW Fortschr Med; 2007 Dec; 149(49-50):20. PubMed ID: 18240436
[No Abstract] [Full Text] [Related]
20. Bronchodilator treatment in asthma. Increase in deaths during salmeterol treatment unexplained.
Sears MR; Taylor DR
BMJ; 1993 Jun; 306(6892):1610-1. PubMed ID: 8101115
[No Abstract] [Full Text] [Related]
[Next] [New Search]
